Navigation Links
Farletuzumab Data Presented on Phase II Clinical Trial in First-Relapsed Ovarian Cancer Subjects
Date:9/24/2009

ody in development for the potential treatment of advanced ovarian cancer. In vitro, farletuzumab appears to have antiproliferative and cytotoxic activities in tumor cells that over express FRA.

A randomized global Phase III study to test farletuzumab in combination with platinum and taxane (P/T) in platinum-sensitive ovarian cancer subjects is currently underway. For more information about the Phase III trial, please visit www.far-trials.com or www.clinicaltrials.gov.

About Morphotek

Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, is a biopharmaceutical company specializing in the development of protein and antibody products through the use of a proprietary gene evolution technology. The technology has been successfully applied to a broad variety of cell lines and organisms to yield genetically diverse offspring that are suitable for product development in the areas of antibody therapeutics, protein therapeutics, product manufacturing, drug target discovery, and improved output traits for commercial applications. The company is currently focusing its platform on the development and manufacturing of therapeutic antibodies for the treatment of cancer, inflammation and infectious disease. For more information, please visit www.morphotek.com.

Eisai Corporation of North America

Eisai Corporation of North America is a wholly-owned subsidiary of Eisai Co., Ltd. and supports the activities of its operating companies in North America. These operating companies include: Eisai Research Institute of Boston, Inc., a discovery operation with strong organic chemistry capabilities; Morphotek, Inc., a biopharmaceutical company specializing in the development of therapeutic monoclonal antibodies
'/>"/>

SOURCE Morphotek(R), Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. OPAXIO(TM) Phase II Trial in Esophageal Cancer to be Presented in Proffered Session at the International Society of Gastrointestinal Oncology Annual Meeting
2. NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
3. ClariVein(TM) Catheter for Varicose Veins: Further Clinical Trial Results to Be Presented
4. Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO-ESMO Congress 2009
5. New Micro-Bland Embolization Technique with Embozene(TM) Microspheres to Be Presented at the International Medical Conference in Lisbon, Portugal
6. QVA149 Phase II Data Presented at the European Respiratory Society Annual Meeting
7. Data From Multiple Clinical Trials of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2009
8. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
9. Late Breaking Clinical Trials Presented at HFSA 13th Annual Scientific Meeting
10. Study on PLC Systems TMR Therapy With Stem Cells Presented at ESC 2009
11. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015 ieCrowd™ today ... the commercial development of the company,s supplemental oxygen ... Oxygen device, being developed by ieCrowd,s subsidiary Smart ... patient,s changing demand for oxygen based on level ... (k) submission for the Smart Oxygen device would ...
(Date:8/27/2015)... Lilly and Company (NYSE: LLY ) will attend ... 17, 2015. Sue Mahony , Ph.D., senior vice ... Gaynor , M.D., senior vice president of product development ... a fireside chat at 3:30 p.m., Eastern Daylight Time. ... available on the "Webcasts & Presentations" section of Lilly,s ...
(Date:8/27/2015)... Women Grow , the fastest-growing professional networking organization for women ... Cannabis World Congress & Business Exposition (CWCBExpo) in ... sessions. CWCBExpo in LA will take place September 16-18, 2015 ... in Los Angeles, CA , and is ... marijuana industry. The Women Grow tracks at ...
Breaking Medicine Technology:Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4Lilly to Participate in Morgan Stanley Global Healthcare Conference 2Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 2Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 3Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 4
... 2011 Reportlinker.com announces that a new market ... Global Freeze Drying Equipment Industry ... report analyzes the worldwide markets for Freeze Drying ... Segments: Laboratory Freeze Drying Equipment, and Pilot & ...
... 16, 2011 Reportlinker.com announces that a new ... Global Blood Processing Supplies And ... This report analyzes the worldwide markets ... Million by the following product segments: Blood Administration ...
Cached Medicine Technology:Global Freeze Drying Equipment Industry 2Global Freeze Drying Equipment Industry 3Global Freeze Drying Equipment Industry 4Global Freeze Drying Equipment Industry 5Global Freeze Drying Equipment Industry 6Global Freeze Drying Equipment Industry 7Global Freeze Drying Equipment Industry 8Global Freeze Drying Equipment Industry 9Global Freeze Drying Equipment Industry 10Global Freeze Drying Equipment Industry 11Global Freeze Drying Equipment Industry 12Global Freeze Drying Equipment Industry 13Global Freeze Drying Equipment Industry 14Global Freeze Drying Equipment Industry 15Global Blood Processing Supplies And Equipment Industry 2Global Blood Processing Supplies And Equipment Industry 3Global Blood Processing Supplies And Equipment Industry 4Global Blood Processing Supplies And Equipment Industry 5Global Blood Processing Supplies And Equipment Industry 6Global Blood Processing Supplies And Equipment Industry 7Global Blood Processing Supplies And Equipment Industry 8Global Blood Processing Supplies And Equipment Industry 9Global Blood Processing Supplies And Equipment Industry 10Global Blood Processing Supplies And Equipment Industry 11Global Blood Processing Supplies And Equipment Industry 12Global Blood Processing Supplies And Equipment Industry 13Global Blood Processing Supplies And Equipment Industry 14Global Blood Processing Supplies And Equipment Industry 15Global Blood Processing Supplies And Equipment Industry 16Global Blood Processing Supplies And Equipment Industry 17Global Blood Processing Supplies And Equipment Industry 18Global Blood Processing Supplies And Equipment Industry 19Global Blood Processing Supplies And Equipment Industry 20Global Blood Processing Supplies And Equipment Industry 21Global Blood Processing Supplies And Equipment Industry 22
(Date:8/28/2015)... ... August 28, 2015 , ... The ... health information technology innovation to transform quality and efficiency of healthcare delivery worldwide, ... be de-identified and aggregated before being publicly shared to document progress and inform ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Database have added comprehensive information on two new duals programs: Rhode Island ... 2015 launch; and Idaho’s partnership to revamp Blue Cross of Idaho’s D-SNP. ...
(Date:8/28/2015)... ... August 28, 2015 , ... Popular ... 5 millionaire dating sites . According to the listings, MillionaireMatch.com ... in this category. , A spokesperson of Top5MillionaireDatingSites.com said, “This website ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Plaintiffs ... as MDL 2545, Testosterone Replacement Therapy Products Liability Litigation, are in the midst ... custodial files the PSC may receive for corporate employees involved in the production ...
(Date:8/28/2015)... ... August 28, 2015 , ... A complimentary webinar offered ... Medicare & Medicaid Services’ (CMS) proposal to mandate bundled payments through the ... “Get Ready for Game Day: Comprehensive Care for Joint Replacement,” takes place at 12 ...
Breaking Medicine News(10 mins):Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2Health News:AIS Duals Database: August Update Finds Two New Duals Programs in Rhode Island and Idaho 2Health News:Top5MillionaireDatingSites.com Publishes Its First List of Reviews of the Best Millionaire Dating Sites 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4Health News:PYA Offers Complimentary CCJR Webina — Game On 2Health News:PYA Offers Complimentary CCJR Webina — Game On 3
... of certified nursing assistants (CNAs) in nursing homes reveals ... one work-related injury in the previous year. One in ... nearly half of those without medical insurance claimed they ... gathered from the first-ever National Nursing Assistant Survey (NNAS), ...
... Veterinary Medical Assn., American Academy of Pediatrics, Unite to ... dog trainer and a descendant of one of the ... States Postal Service and other partners to bring attention ... trainer Bob Weatherwax, son of Rudd Weatherwax, who established ...
... NxStage Medical, Inc. (Nasdaq: NXTM ), a leading ... recognized as the fourth largest revenue gainer in Massachusetts by the ... NxStage is also the 111th company on the BBJ ,s ... 2008 revenue. The full list of the BBJ 150 ...
... Sunstone,Corporation (Nasdaq: BJGP ) ("BMP Sunstone" or ... first quarter 2009 financial results on,Monday, May 18, 2009, ... The Company will hold a conference call at 5:00 ... 2009 results. Listeners may access the call by ...
... Used in Cimzia(R) Through Exclusive Nektar-UCB CollaborationSAN FRANCISCO, ... NKTR ) confirmed today UCB,s announcement that ... approved Cimzia(R) (certolizumab pegol), the only PEGylated anti-TNFa ... adult patients with moderately to severely active rheumatoid ...
... Treating a common heart rhythm disorder by burning heart ... treatments, a major international study has found. , One ... percent of patients with an irregular heartbeat called atrial ... symptoms. By comparison, only 17 percent of those treated ...
Cached Medicine News:Health News:Nursing assistant workforce facing financial, health challenges 2Health News:Famed Hollywood Dog Trainer and Lassie Descendant Unleash National Dog Bite Prevention Week, May 14 2Health News:Famed Hollywood Dog Trainer and Lassie Descendant Unleash National Dog Bite Prevention Week, May 14 3Health News:Famed Hollywood Dog Trainer and Lassie Descendant Unleash National Dog Bite Prevention Week, May 14 4Health News:Famed Hollywood Dog Trainer and Lassie Descendant Unleash National Dog Bite Prevention Week, May 14 5Health News:NxStage Ranked Fourth Largest Revenue Gaining Company in Massachusetts for 2008 2Health News:BMP Sunstone To Report First Quarter 2009 Financial Results 2Health News:Nektar Announces UCB's Cimzia(R) Approved by U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 2Health News:Nektar Announces UCB's Cimzia(R) Approved by U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 3Health News:Heating heart with catheter better than drugs for common heart rhythm disorder 2Health News:Heating heart with catheter better than drugs for common heart rhythm disorder 3
Inquire...
Inquire...
Inquire...
The modular, high-end stereomicroscope; meets even the most critical demands in research and quality control provides high-contrast images with excellent depth of field and color fidelity...
Medicine Products: